Literature DB >> 14751778

Motor phenotypic alterations in TgDyrk1a transgenic mice implicate DYRK1A in Down syndrome motor dysfunction.

M Martínez de Lagrán1, X Altafaj, X Gallego, E Martí, X Estivill, I Sahún, C Fillat, M Dierssen.   

Abstract

Motor deficits are among the most frequent impairments in Down syndrome (DS), but their neuropathological and molecular bases remain elusive. Here we investigate the motor profile of transgenic mice overexpressing Dyrk1a, Tg(Dyrk1a)1Cff (hereafter TgDyrk1a), a candidate gene hypothesized to cause some of the neurological defects associated with DS. We have previously shown DYRK1A expression in the cerebellum and functionally related structures, most brainstem motor nuclei and spinal cord, supporting a role for Dyrk1a in controlling motor function. Here we demonstrate that TgDyrk1a mice present DYRK1A overexpression in these areas along with specific motor dysfunction. The main finding that emerged was impairment of motor learning and alteration of the organization of locomotor behavior, which agrees with reported clinical observations in subjects with DS. These results confirm and extend previous data and provide further insight to the functional domains that might be altered in TgDyrk1a mice and underlying molecular mechanisms of DS motor dysfunction.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14751778     DOI: 10.1016/j.nbd.2003.10.002

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  31 in total

Review 1.  Trisomy 21 and early brain development.

Authors:  Tarik F Haydar; Roger H Reeves
Journal:  Trends Neurosci       Date:  2011-12-09       Impact factor: 13.837

2.  The Drosophila wings apart gene anchors a novel, evolutionarily conserved pathway of neuromuscular development.

Authors:  Ginny R Morriss; Carmelita T Jaramillo; Crystal M Mikolajczak; Sandy Duong; Maryann S Jaramillo; Richard M Cripps
Journal:  Genetics       Date:  2013-09-11       Impact factor: 4.562

3.  Upregulation of three Drosophila homologs of human chromosome 21 genes alters synaptic function: implications for Down syndrome.

Authors:  Karen T Chang; Kyung-Tai Min
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-21       Impact factor: 11.205

4.  Epigallocatechin-3-gallate (EGCG) consumption in the Ts65Dn model of Down syndrome fails to improve behavioral deficits and is detrimental to skeletal phenotypes.

Authors:  Megan Stringer; Irushi Abeysekera; Jared Thomas; Jonathan LaCombe; Kailey Stancombe; Robert J Stewart; Karl J Dria; Joseph M Wallace; Charles R Goodlett; Randall J Roper
Journal:  Physiol Behav       Date:  2017-05-03

5.  The molecular chaperone TRiC/CCT binds to the Trp-Asp 40 (WD40) repeat protein WDR68 and promotes its folding, protein kinase DYRK1A binding, and nuclear accumulation.

Authors:  Yoshihiko Miyata; Takeshi Shibata; Masato Aoshima; Takuichi Tsubata; Eisuke Nishida
Journal:  J Biol Chem       Date:  2014-10-22       Impact factor: 5.157

6.  Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A.

Authors:  Yasushi Ogawa; Yosuke Nonaka; Toshiyasu Goto; Eriko Ohnishi; Toshiyuki Hiramatsu; Isao Kii; Miyo Yoshida; Teikichi Ikura; Hiroshi Onogi; Hiroshi Shibuya; Takamitsu Hosoya; Nobutoshi Ito; Masatoshi Hagiwara
Journal:  Nat Commun       Date:  2010-10-05       Impact factor: 14.919

7.  Pioglitazone halts axonal degeneration in a mouse model of X-linked adrenoleukodystrophy.

Authors:  Laia Morató; Jorge Galino; Montserrat Ruiz; Noel Ylagan Calingasan; Anatoly A Starkov; Magali Dumont; Alba Naudí; Juan José Martínez; Patrick Aubourg; Manuel Portero-Otín; Reinald Pamplona; Elena Galea; M Flint Beal; Isidre Ferrer; Stéphane Fourcade; Aurora Pujol
Journal:  Brain       Date:  2013-06-22       Impact factor: 13.501

8.  Clinical-psychological characteristics of children with dysgenesis of the cerebellar vermis.

Authors:  M Yu Bobylova; A S Petrukhin; G N Dunaevskaya; S V Piliya; E S Il'ina
Journal:  Neurosci Behav Physiol       Date:  2007-10

9.  Truncation of the Down syndrome candidate gene DYRK1A in two unrelated patients with microcephaly.

Authors:  Rikke S Møller; Sabine Kübart; Maria Hoeltzenbein; Babett Heye; Ida Vogel; Christian P Hansen; Corinna Menzel; Reinhard Ullmann; Niels Tommerup; Hans-Hilger Ropers; Zeynep Tümer; Vera M Kalscheuer
Journal:  Am J Hum Genet       Date:  2008-04-10       Impact factor: 11.025

10.  Targeting Dyrk1A with AAVshRNA attenuates motor alterations in TgDyrk1A, a mouse model of Down syndrome.

Authors:  Jon Ortiz-Abalia; Ignasi Sahún; Xavier Altafaj; Núria Andreu; Xavier Estivill; Mara Dierssen; Cristina Fillat
Journal:  Am J Hum Genet       Date:  2008-10       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.